Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318929 · ClinicalTrials.gov registry record · NA
Tolerability and Efficacy of Depakote-extended Release in the Elderly
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00318929 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 14 participants.
The verdict
NCT00318929, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
There is a bimodal distribution to the new onset seizures with one peak occurring in the very young and the second peak occurring in persons over age 65 years. The presentation of seizures in the elderly may vary from that of younger patients and the diagnosis may be confused with other conditions such as transient ischemic attacks. However, the consequences of epilepsy in the elderly can be severe leading to impaired cognition, increased falls, and a decreased quality of life. The treatment of epilepsy may be complicated by pharmacokinetic and pharmacodynamic changes occurring in the elderly.
Interventions
- DRUG Divalproex Sodium Extended-Release Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00318929
The ClinicalTrials.gov registry entry for NCT00318929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex Sodium Extended-Release Tablets is the first listed.
NCT00318929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00318929 about?
NCT00318929 is a clinical study titled "Tolerability and Efficacy of Depakote-extended Release in the Elderly". There is a bimodal distribution to the new onset seizures with one peak occurring in the very young and the second peak occurring in persons over age 65 years. The presentation of seizures in the elderly may vary from that of younger patients and the diagnosis may be confused with other conditions s...
What is the current status of trial NCT00318929?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2006-04. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00318929?
The interventions under investigation include: Divalproex Sodium Extended-Release Tablets (DRUG).
Who is sponsoring clinical trial NCT00318929?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.